-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2018 to 2023.
- Akero Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $57.8M, a 229% increase year-over-year.
- Akero Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$224M, a 250% decline from 2022.
- Akero Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$63.8M, a 251% decline from 2021.
- Akero Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $42.3M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)